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Abstract
Cellular adaptation to hypoxic conditions mainly involves transcriptional changes in which hypoxia inducible factors (HIFs)
play a critical role. Under hypoxic conditions, HIF protein is stabilized due to inhibition of the activity of prolyl hydroxylases
(EGLNs). Because the reaction carried out by these enzymes uses oxygen as a co-substrate it is generally accepted that the
hypoxic inhibition of EGLNs is due to the reduction in oxygen levels. However, several studies have reported that hypoxic
generation of mitochondrial reactive oxygen species (ROS) is required for HIF stabilization. Here, we show that hypoxia
downregulates thioredoxin reductase 1 (TR1) mRNA and protein levels. This hypoxic TR1 regulation is HIF independent, as
HIF stabilization by EGLNs inhibitors does not affect TR1 expression and HIF deficiency does not block TR1 hypoxic-
regulation, and it has an effect on TR1 function, as hypoxic conditions also reduce TR1 activity. We found that, when
cultured under hypoxic conditions, TR1 deficient cells showed a larger accumulation of ROS compared to control cells,
whereas TR1 over-expression was able to block the hypoxic generation of ROS. Furthermore, the changes in ROS levels
observed in TR1 deficient or TR1 over-expressing cells did not affect HIF stabilization or function. These results indicate that
hypoxic TR1 down-regulation is important in maintaining high levels of ROS under hypoxic conditions and that HIF
stabilization and activity do not require hypoxic generation of ROS.
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Introduction
Hypoxia, defined as a decrease in oxygen levels, is a common
feature of physiological and pathological processes, including
embryonic development, adaptation to high altitudes, wound
healing, inflammation, ischemic diseases and solid cancer growth.
In response to hypoxic conditions, mammalian cells undergo
adaptive changes through modulation of gene expression in which
the hypoxia inducible factors (HIF) play a key role [1–2]. HIF is a
heterodimeric transcription factor composed of an a subunit,
which under normoxic conditions is degraded by the proteasome,
and a b subunit, whose protein levels are not affected by hypoxia.
The intracellular oxygen level is sensed by a family of prolyl
hydroxylases, EGLN1, EGLN2 and EGLN3 (also known as
PHD2, PHD1 and PHD3, respectively), which hydroxylate two
proline residues at the oxygen-dependent domain (ODD) of HIF-a
subunits using oxygen, 2-oxoglutarate and Fe
2+ as co-substrates
[3–4]. The hydroxyprolines are then recognized by the Von
Hippel Lindau protein (VHL) which promotes the ubiquitination
of HIF-a thereby targeting it for proteasome degradation. Under
hypoxic conditions, the enzymatic activity of the prolyl hydrox-
ylases is impaired and, therefore, HIF-a is no longer hydroxylated
and its interaction and ubiquitination by VHL no longer occurs.
This leads to its accumulation, translocation to the nucleus,
dimerization with the b subunit and regulation of its target genes.
It is generally accepted that hypoxic conditions modify reactive
oxygen species (ROS) levels in cells, although it is still debated in
which direction this change occurs. Several studies using different
technologies for the measurement of ROS have demonstrated an
increase in ROS intracellular levels under hypoxic conditions. The
increase of ROS levels upon hypoxia treatment requires a
functional complex III of the mitochondrial electron transporter
chain (ETC) and hypoxic stabilization of HIF appears to be
dependent on the hypoxia-induced generation of ROS [5–7].
However, the induction of mitochondrial ROS under hypoxic
conditions is controversial. Other studies have shown either a
hypoxia-induced decrease in the mitochondrial generation of ROS
[8], or no correlation between hypoxic stabilization of HIF and
mitochondrial ROS levels [9–11].
There are several mechanisms that cells use to maintain the
levels of H2O2 and minimize promiscuous oxidation reactions.
Among them, the consumption of H2O2 by cellular thiols is a
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systems control the thiol redox status in the cell, the thioredoxin
system and the glutathione system. H2O2 is consumed through
these two systems by reactions with peroxiredoxins (Prx) and
glutathione peroxidase 1 (Gpx1). Several Prxs are dithiol-
containing enzymes that are oxidized by H2O2 to the disulfide,
and reduced by thioredoxin, which in turn is reduced by the
selenocysteine-containing thioredoxin reductase 1 (TR1). On the
other hand, Gpx1 uses selenocysteine to reduce H2O2, generating
a selenenic acid that is reduced using glutathione.
Although ROS can function as second messengers in cell
signaling at a low concentration, at high concentrations cells try to
alleviate oxidative stress through changes in gene expression [12].
Nrf2 is one of the transcription factors that responds to an increase
in ROS levels and, among other antioxidant genes, regulates Gpx2
expression [13]. Therefore, Gpx2 and TR1, among other
selenoproteins, play a key role in the maintenance of a redox
balance inside the cells. However, little is known about their role in
the cellular response to hypoxic conditions.
In this study, we show that hypoxia leads to a significant down-
regulation of both, protein and mRNA levels of TR1. Using siRNA
todownregulateHIF-1a and iron chelators for inhibitingthe activity
of prolyl hydroxylases we demonstrate that HIF-1a is not sufficient
or necessary for the hypoxia-induced down-regulation of TR1. We
further show that TR1 over-expression attenuates the hypoxia-
induced increase of ROS, whereas TR1 deficiency potentiates the
elevation in ROS levels induced by hypoxia. However, neither TR1
over-expression nor TR1 down-regulation affect HIF stabilization
or activity under hypoxic conditions. This study establishes a new
mechanism by which high levels of ROS could be maintained under
hypoxic conditions and support the notion that hypoxic HIF
regulation occurs independently of ROS production.
Methods
Cell culture and reagents
DT cells, which were derived from the parental NIH 3T3 cells
by expressing the oncogenic k-ras genes [14], were grown in
Dulbecco’s Minimum Essential Medium (DMEM) (Invitrogen,
Carlsbad, CA) supplemented with 10% fetal bovine serum (Gibco
Invitrogen) and the mouse breast carcinoma cell line, EMT6, was
grown in Waymouth’s Medium (Invitrogen) supplemented with
15% fetal bovine serum. In both cell lines, an antibiotic-
antimicotic solution (Invitrogen) was added to the culture media
and cells were maintained in a humidified atmosphere containing
5% CO2 at 37uC. Hypoxia (1% O2) was induced by culturing the
cells inside a modular incubator chamber (model MIC-101 by
Billups-Rothenberg Inc., Del Mar, CA) with inflow and outflow
valves that was infused with a mixture of 1% O2,5 %C O 2, and
94% N2. Where indicated, Deferoxamine or L-Mimosine (Sigma-
Aldrich, St. Louis, MO) was added to the culture media at a
concentration of 150 mM and 100 mM, respectively.
Constructs
TR1 and HIF-1a RNAi target sequences have been reported
previously [15,16]. Sense-antisense primers for HIF-1a and TR1
knockdown were annealed and cloned into the BglII-HindIII sites
in pSuper Retro Puro following the manufacturer’s instructions
(Oligoengine, Seattle,WA). TR1 mRNA was amplified by PCR
from pcDNA 3.1 TR1-3mD [17] and cloned into SmaI-EcoRI
sites of pTriex-4 Hygro Vector. The final TR1 construct with His
and S tags was amplified from this vector by PCR with the primers
1+2 (Table 1) and cloned into BamHI-EcoRI sites of the retroviral
vector pRV IRES Puro. pRV IRES Puro plamid was generated
from the vector pLZR IRES GFP (kindly provided by Dr. Antonio
Bernad, CNIC, Madrid, Spain) by substituting the GFP gene for
the puromycin resistance gene.
Retroviral production and cell line infection
GP2-293 cells (Clontech, Palo Alto, CA) were transfected in 60-
mm dishes using LipoD293 (SignaGen Laboratories, Gaithers-
burg, MD) following manufacturer’s instructions. 1.5 mg of each
retroviral vector and 1 mg of amphotropic envelope expression
vector (pVSV-G) were used. Medium was changed 24 h folowing
transfection. Cell culture supernatants were harvested after an
additional 24 h, filtered with 0.22 mm filters, and diluted (1:2) with
fresh medium. Diluted viral supernatants containing 6 mg/mL
polybrene were then added to the cells (plated at a low confluency
24 h prior to the infection) and incubated overnight at 37uC.
Western blotting
After treatment, cells were washed with ice-cold phosphate-
buffered saline (PBS) and harvested with Mammalian Protein
Extraction Reagent (M-PER) (Thermo Scientific, Rockford, IL).
The amount of protein in cell extracts was measured using the BCA
proteinassay.Protein lysateswereresolvedonNuPAGE4–12%Bis-
Tris gels (Invitrogen). Proteins were transferred to nitrocellulose
membranes (Invitrogen) using electroblotting procedures. Nitrocel-
lulose membranes were blocked with 5% non-fat dry milk in TBS-T
(50 mM Tris, pH 7.6, 150 mM NaCl, 0.1% Tween 20) and
incubated overnight at 4uC with the indicated antibodies (anti- HIF-
1a, MAB1536 from R&D Systems, Minneapolis, MN; polyclonal
anti-TR1; polyclonal anti-actin, sc-1615 from Santa Cruz, Santa
Cruz, Ca). Immunolabeling was detected by enhanced chemilumi-
nescence(SuperSignalWestDura,ThermoScientific)andvisualized
with a digital luminescent image analyzer (Fujifilm LAS-3000).
75Se-labeling of cells
Cells were seeded into 6-well plates, incubated for 24 h, labeled
with 30 mCi of
75Se, cultured under normoxic or hypoxic
conditions for 12 h and then harvested and lysed as described
above. 30 mg of each sample were applied to a NuPAGE 4–12%
Bis-Tris gel, electrophoresed and proteins stained with Coomassie
Blue. The gel was then dried and exposed to a PhosphorImager
(Molecular Dynamics, GE Healthcare).
75Se-labeled selenopro-
teins were identified by autoradiography.
Table 1. Oligonucleotide probes used in this study.
No. Target Direction Sequence
1 TR1 F TTAATGGATCCGGAGATATACCATGGCACACCAT
2 TR1 R AAATGAATTCTCGTTTTGGACACAAGA
3 HIF1-a F ACCTACTATGTCACTTTCCTG
4 HIF1-a R TTCTGCTGCCTTGTATGG
5 TR1 F CAGATGGGGTCTCGGAGGAA
6 TR1 R GTGACTCTGCACAGATTCCGTCAT
7 VEGF F TGCCAAGTGGTCCCAG
8 VEGF R GTGAGGTTTGATCCGC
9 ADM F GTTTCCGTCGCCCTGATG
10 ADM R CCCACTTATTCCACTTCTTTCG
11 Actin F CCCAGAGCAAGAGAGG
12 Actin R GTCCAGACGCAGGATG
doi:10.1371/journal.pone.0030470.t001
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Total RNA was extracted from the cells using RNeasy mini Kit
(Qiagen, Valencia, CA). cDNA was synthesized from 2 mg of total
RNA using Impron II Reverse Transcriptase (Promega, Madison,
WI). For real-time quantitative PCR, 1 ml of cDNA was used as
template in a 25 ml reaction carried out with the POWER SYBR
Master mix kit (Applied Biosystems, Carlsbad, CA) following the
manufacturer’s instructions. PCR amplifications were carried out
in MyiQ Two-Color Real-Time PCR Detection System (BioRad,
Hercules, CA). To avoid amplification of potential genomic DNA
contaminants, the primer pairs used in this study were chosen to
hybridize to different exons of the target genes (Table 1, Primers
3–12). The mRNA levels of target genes were calculated relative to
the expression of b-actin.
Thioredoxin reductase activity
Thioredoxin reductase activity was measured as previously
described [18]. Briefly EMT6 or DT cells were grown under
normoxic/hypoxic conditions or treated with deferoxamine. After
12 h, cells were harvested and resuspended in phosphate buffer
and then sonicated for 30 sec on ice. The TR activity was
measured in the extracts by subtracting the time-dependent
increase in absorbance at 412 nm. A unit of activity was defined as
1.0 mmol of 5-thio-2-nitrobenzoic acid formed/min/mg protein.
Protein concentration was measured using the BCA (Bicinchoninic
acid) assay (Thermo Fisher Scientific).
Intracellular ROS measurement
Cells were seeded into 6-well plates, incubated for 24 h and
exposed to 10 mg/ml of 5-(and-6)-chloromethyl-2979-dichlorodi-
hydrofluorescein diacetate acetyl ester (H2DCFDA) for 30 min.
Then the medium was replaced and cells incubated for 12 h
under normoxic or hypoxic conditions. H2DCFDA-stained cells
were harvested with a cell lifter, washed with ice-cold PBS and
fluorescence of DCFDA measured by flow cytometry using a
FACSCalibur 2 cytometer (Becton Dickinson, Franklin Lakes,
NJ).
Statistical analyses
Data are presented as the mean 6 SE. Differences between
means were determined by Student’s t-test using Microsoft Excel.
Differences were considered statistically significant at p,0.05.
Figure 1. Effect of hypoxic conditions on TR1 mRNA and protein levels. (A) EMT6 cells were labeled with
75Se and incubated under
normoxic (Nx) or hypoxic (Hx) conditions for 12 h. Cells were lysed and selenoprotein levels analyzed by autoradiography (left panel). Protein
standards are shown in lane 1 and protein extracts of EMT6 cells cultured in (lane 2) normoxic or (lane3) hypoxic conditions (right panel). (B) TR1
protein levels were analyzed by western blotting in EMT6 and DT cell lines grown under normoxic (Nx) or hypoxic (Hx) conditions for 12 h. (C) EMT6
and (D) DT cell lines were grown under normoxic (Nx) or hypoxic (Hx) conditions and the mRNA levels of TR1, VEGF and ADM determined by
quantitative RT-PCR and normalized to the content of b-actin mRNA in the same sample. The data represent the fold induction of each mRNA over
the mean from the normoxic values. The mean from 3 different experiments 6 SE is shown.
doi:10.1371/journal.pone.0030470.g001
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Hypoxia down-regulates TR1 mRNA and protein levels
EMT6 cells were metabolically labeled with
75Se and then
incubated under normoxic (21% O2) or hypoxic (1% O2)
conditions for 12 h (Fig. 1A). Hypoxia treatment appeared to
cause a decrease in TR1 levels, whereas the expression of other
selenoproteins was not significantly affected. The reduction in
TR1 protein levels by the hypoxic condition was confirmed by
western blotting using specific antibodies against TR1 in both
EMT6 and DT cell lines (Fig. 1B).
To assess whether hypoxia treatment affected TR1 gene
expression levels, we determined TR1 mRNA levels under
normoxic or hypoxic conditions. Quantitative RT-PCR showed
a significant decrease of TR1 mRNA levels in the cells grown
under hypoxic conditions compared to the levels found in the cells
grown under normoxic conditions (Fig. 1C and 1D). To monitor
the hypoxic conditions we measured the mRNA levels of vascular
endothelial growth factor (VEGF) and adrenomedullin (ADM), as
both genes are well known to be induced under hypoxic conditions
[19–21]. As expected, EMT6 and DT cells exposed to hypoxia
showed a significant increase in both VEGF and ADM mRNA
levels (Fig. 1C and 1D).
HIF is neither sufficient nor necessary for hypoxia-
induced TR1 down-regulation
Due to the major role of HIF in the regulation of hypoxia-
induced changes in gene expression, we investigated whether the
reduction of TR1 expression under hypoxia was HIF-dependent.
The inhibition of EGLNs leads to HIF stabilization and induction
of HIF-target genes [22]. We therefore assessed whether the use of
EGLN inhibitors would have the same effect on TR1 levels as
hypoxia treatment. DT and EMT6 were treated with the iron
chelator deferoxamine or the 2-oxoglutarate analog L-mimosine.
As shown in Fig. 2A, deferoxamine and L-mimosine treatment
resulted in HIF-1a stabilization in both, DT and EMT6 cell lines.
This stabilization of HIF-1a correlated with an increase in the
expression of HIF-target genes, VEGF and ADM, in DT (Fig. 2B)
and EMT6 cells (Fig. 2C). However, the treatment with
deferoxamine or L-mimosine in DT and EMT6 did not affect
significantly TR1 mRNA (Fig. 2B and 2C) or protein levels
(Fig. 2A), indicating that HIF stabilization/activity is not sufficient
for TR1 down-regulation.
We then examined whether HIF-1a was necessary for the
hypoxia-induced decrease of TR1 levels. To this end, EMT6 and
DT cells were infected with retroviruses encoding siHIF-1a or a
scrambled sequence (SCR). HIF-1a knockdown cells exposed to
Figure 2. Effect of HIF-1a stabilization by EGLN inhibitors on TR1 expression. (A) EMT6 and DT cells were treated with 150 mMo f
deferoxamine (DFX), 100 mM of L-mimosine (LM) or left untreated (Ctrl) for 12 h and the levels of HIF-1a and TR1 protein detected by western
blotting. The mRNA levels of TR1, VEGF and ADM from (B) EMT6 cells and (C) DT cells, treated with deferoxamine (DFX) or left untreated (Ctrl) for 8 h,
were measured by quantitative RT-PCR. The data represent the fold-change relative to untreated cells after normalization with the b-actin content.
The mean and 6 SE of 3 independent experiments is shown.
doi:10.1371/journal.pone.0030470.g002
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3B) compared to respective control cells. This reduction in HIF-1a
protein correlated with a reduced hypoxic-induction of HIF-target
genes, VEGF and ADM, in HIF knockdown cells compared to the
cells infected with the retrovirus encoding the scramble sequence
(Fig. 3C and 3D). However, no significant effect was observed in
the hypoxia-induced reduction of TR1 protein (Fig. 3A and 3B)
and mRNA levels (Fig. 3C and 3D).
TR1 activity is reduced in cells exposed to hypoxia
To assess whether the reduction in TR1 levels resulted in a
reductionof the activity of this enzyme, we determined TR1activity
in EMT6 and DT cells cultured under hypoxic conditions. As
shown in Fig. 4A, hypoxia treatment significantly reduced TR1
activity in both EMT6 and DT cells. On the contrary, the use of the
EGLNs inhibitor, deferoxamine, did not affect TR1 activity
(Fig. 4B). Furthermore, EMT6 and DT HIF-1a knockdown cells
exposed to hypoxic conditions showed a decrease in TR1 activity
similar to the decrease observed in the hypoxic treated control cells
(Fig. 4C). These results show that the reduction in TR1 mRNA and
protein levelsunder hypoxic conditions alsoresulted ina decrease in
TR1 activity, and that this reduction in TR1 activity, as the
decrease in TR1 mRNA and protein levels, is HIF-1a independent.
TR1 deficiency increases the hypoxia-induced generation
of ROS
In order to study the importance of hypoxia-induced down-
regulation of TR1 in the increase of ROS levels observed under
low oxygen levels conditions, we generated EMT6 and DT cells in
which TR1 expression was knocked down reducing TR1 mRNA
levels more than 80% compared to control cells (Fig. S1). Both cell
lines were cultured under normoxic or hypoxic conditions and the
highly sensitive H2DCFDA probe was used for measuring
intracellular ROS levels [23–24]. As shown in Fig. 5A and 5B,
although hypoxia significantly increased ROS levels in both
control and TR1 knockdown cells, the increase in ROS levels in
TR1 knockdown cells cultured under hypoxic conditions was
significantly higher than in the control cells. The knockdown of
TR1, however, did not increase significantly the ROS levels under
normoxic conditions (Fig. 5A and 5B).
ROS generated under hypoxic conditions have been shown to
be required for the inhibition of the activity of the EGLN enzymes
responsible for hypoxic HIF stabilization. Considering the increase
that we observed in the hypoxic ROS levels in cells in which TR1
was knocked down compared to control cells, we assessed whether
HIF stabilization or activity could be increased under these
conditions. However, we were unable to find differences in HIF
Figure 3. Hypoxic regulation of TR1 expression in HIF-1a deficient cells. TR1 and HIF-1a protein levels, from (A) EMT6 cells and (B) DT cells
infected with retrovirus encoding a scramble sequence (SCR) or a HIF-1a shRNA (si HIF-1a) and cultured under normoxic (Nx) or hypoxic (Hx)
conditions for 12 h, were determined by western blotting. (C) EMT6 cells or (D) DT cells infected with the indicated retroviruses were cultivated for
12 h under normoxic (Nx) or hypoxic conditions (Hx) and TR1, VEGF and ADM mRNA levels measured by quantitative RT-PCR. The fold-change
relative to the normoxic values and normalized with the b-actin is shown. Data represent the mean and 6 SE of 3 independent experiments.
doi:10.1371/journal.pone.0030470.g003
Hypoxic Regulation of Thioredoxin Reductase 1
PLoS ONE | www.plosone.org 5 February 2012 | Volume 7 | Issue 2 | e30470protein levels (Fig. 5C and 5D) or in the induction of the HIF
target genes, VEGF and ADM, in the TR1 knockdown cells
compared to the control cells (Fig. 5E and 5F).
TR1 overexpression inhibits the increase in ROS induced
by hypoxia
Due to the effect on the ROS generation under hypoxic
conditions observed in TR1 deficient cells, we examined whether
the over-expression of TR1 could affect the hypoxia-induced
generation of ROS. We therefore generated EMT6 and DT TR1
over-expressing cells. TR1 mRNA and protein levels were highly
elevated in over-expressing cells compared to control cells (Fig.
S2). We then exposed control and TR1 over-expressing cells to
hypoxic or normoxic conditions and total ROS production was
analyzed as described in Methods. As a positive control for ROS
generation cells were treated with H2O2 for 10 minutes. This
treatment resulted in a significant increase in the ROS levels in
both control and TR1 over-expressing cell lines (Fig. 6A and 6B).
However, hypoxic conditions significantly elevated ROS only in
the control cells, but not in the TR1 over-expressing cells (Fig. 6A
and 6B).
Other studies have shown that ROS generated under hypoxic
conditions at the mitochondrial level are essential for HIF
stabilization. Since we did not observe a significant increase in
ROS levels in TR1 over-expressing cells under hypoxic conditions
compared to normoxic conditions, we examined how TR1 over-
expression affected HIF stabilization or activity. DT and EMT6
TR1 over-expressing cells were cultured under normoxic or
hypoxic conditions and HIF-1a protein levels analyzed by western
blotting. No significant changes in HIF-1a protein levels were
found in TR1 over-expressing DT or EMT6 cells compared to
control cells (Fig. 6C and 6D). Furthermore, the analysis of the
mRNA of the HIF target genes VEGF and ADM demonstrated
that the activity of HIF was not affected by blocking the
production of ROS under hypoxic conditions by over-expressing
TR1 (Fig. 6E and 6F).
Figure 4. Effect of hypoxic conditions, EGLN inhibitors or HIF-1a deficiency on TR1 activity. (A) TR1 activity was measured as indicated in
Methods in EMT6 and DT cells grown under normoxic (Nx) or hypoxic (Hx) conditions for 12 h. (B) EMT6 and DT cells were treated with 150 mM
deferoxamine (DFX) or left untreated (Ctrl) for 12 h and TR1 activity measured. (C) EMT6 and DT cells infected with retrovirus encoding a scramble
sequence (SCR) or a HIF-1a shRNA (si HIF-1a) were cultured under normoxic (Nx) or hypoxic (Hx) conditions for 12 h and TR1 activity measured. Data
represent the means of 3 independent experiments 6 SE.
doi:10.1371/journal.pone.0030470.g004
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To determine whether hypoxia affects selenoprotein expression,
we cultured
75Se-labeled EMT6 cells under hypoxic conditions
and found that TR1 levels were significantly reduced compared to
the TR1 levels of EMT6 cells cultured under normoxic conditions.
This reduction in TR1 protein levels was also found by western
blotting using a specific antibody against TR1. Furthermore,
quantitative PCR demonstrated a down-regulation of TR1 mRNA
levels, suggesting that the decrease in TR1 levels is achieved
through transcriptional regulation.
HIF is the major transcription factor implicated in gene
expression changes induced by hypoxia. Although most of its
target genes are up-regulated after HIF stabilization and activation
[25], there are also genes that have been shown to be down-
regulated in a HIF-dependent manner under hypoxic conditions
[26,27]. In our study we showed, by inhibiting the activity of the
EGLNs, that HIF stabilization was not sufficient to reduce TR1
levels. Moreover, the use of a retrovirus to knockdown the
expression of HIF-1a did not have any effect on the hypoxia-
induced decrease of TR1 levels. Therefore, HIF is neither
sufficient nor required for TR1 regulation upon hypoxic
conditions.
In addition, we found a decrease in TR1 activity in cells
cultured under hypoxic conditions that was also independent of
HIF stabilization or activity. Interestingly, TR1 activity was
decreased to a greater extent than its mRNA and protein levels,
suggesting that the hypoxic effects on TR1 could involve
mechanisms other than a change in expression levels; e.g.,
translational or post-translational modification of TR1 that affects
its activity. In addition, other components involved in the
thioredoxin reductase reaction could be affected by hypoxic
Figure 5. Effect of TR1 deficiency on ROS levels and HIF activity in cells cultured under hypoxic conditions. (A) EMT6 and (B) DT cells
infected with retroviruses encoding a scramble sequence (SCR) or a TR1 shRNA (siTR1) were grown under normoxic (Nx) or hypoxic (Hx) conditions
for 12 h and ROS levels determined as described in Methods. As a positive control for ROS generation, cells were treated with 100 mMo fH 2O2 where
indicated. Data represent the fluorescence value of each sample after subtracting the fluorescence value from unstained control cells. The mean 6 SE
of 3–4 independent experiments is shown. HIF-1a, TR1 and b-actin protein levels were determined by western blotting in (C) EMT6 and (D) DT cells
infected with retroviruses encoding a scramble sequence (SCR) or a TR1 shRNA (siTR1) and cultured under normoxic (Nx) or hypoxic (Hx) conditions
for 12 h. mRNA levels of the HIF target genes, VEGF and ADM, were analyzed by quantitative RT-PCR in (E) EMT6 or (F) DT cell lines infected with
retroviruses encoding a scramble sequence (SCR) or a TR1 shRNA (siTR1) and cultured under normoxic (Nx) or hypoxic (Hx) conditions for 12 h. Data
show the means of 3 independent experiments 6 SE.
doi:10.1371/journal.pone.0030470.g005
Hypoxic Regulation of Thioredoxin Reductase 1
PLoS ONE | www.plosone.org 7 February 2012 | Volume 7 | Issue 2 | e30470conditions. Further study is required to elucidate the precise
mechanism(s) responsible for this anomaly.
To our knowledge, this is the first report showing a down-
regulation of TR1 protein and mRNA by hypoxic conditions. This
result suggests that the increase in ROS levels observed under
hypoxic conditions could be due not only to an increase in ROS
generation, but also to a decrease in the activity in one of the
major cellular antioxidant systems, e.g. the thioredoxin/thiore-
doxin reductase system [28]. Although ETC is frequently cited as
the most important source of ROS (see [29] and references
therein), the NADPH oxidase system can also produce intracel-
lular ROS in some cell types and several studies have found a
reduction in the specific ROS generated by this system after
hypoxic treatment [30–32]. Under such conditions, an increase in
ROS could be explained by a reduction in the activity of the
systems required to reduce intracellular ROS levels. In agreement
with this proposal, we found that TR1 knockdown elevated the
ROS levels induced by hypoxia whereas the over-expression of
TR1 was able to avoid ROS accumulation under hypoxic
conditions. However, this result does not exclude the possibility
of an increase in the generation of ROS in the mitochondrial in
response to hypoxic conditions.
It has been reported that the increase in ROS levels observed
under hypoxic conditions could be crucial for cellular oxygen
sensing and the activation of the hypoxic adaptive response
[33,34]. These earlier studies maintained that ROS generated in
hypoxia are required for the complete inhibition of the activity of
the EGLNs. However the Km values for O2 of the three EGLNs
have been shown to be close to the atmospheric oxygen
concentration, and thus even small decreases in O2 levels are
likely to influence their activities [35]. In contrast to these studies,
we found that a larger increase in ROS levels under hypoxic
Figure 6. ROS levels and HIF stabilization and activity in hypoxic TR1 over-expressing cells. ROS levels were determined in (A) EMT6 and
(B) DT cells infected with retroviruses encoding the TR1 gene (TR1) or empty retroviruses (Ctrl) and cultured under normoxic (Nx) or hypoxic (Hx)
conditions for 12 h. Data represent the fluorescence value of each sample after subtracting the fluorescence value from unstained control cells. The
mean 6 SE of 4–7 independent experiments is shown. Protein levels of HIF-1a and TR1 were determined by western blotting in (C) EMT6 and (D) DT
cells infected with empty retroviruses (Ctrl) or retroviruses encoding the TR1 gene (TR1) and cultured for 12 h under normoxic (Nx) or hypoxic (Hx)
conditions. VEGF and ADM mRNA levels were analyzed by quantitative RT-PCR in EMT6 (E) or DT (F) cell lines with retroviruses encoding the TR1 gene
(TR1) or with empty retroviruses (Ctrl) and cultured under normoxic (Nx) or hypoxic (Hx) conditions for 12 h. Data show the means of 3 independent
experiments 6 SE.
doi:10.1371/journal.pone.0030470.g006
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have an effect on HIF-1a stabilization or activity. Furthermore,
the over-expression of TR1, that was able to block the increase in
ROS levels under hypoxia, did not affect HIF-1a protein
stabilization or activity. These results suggest that ROS generated
under hypoxic conditions are not required for the inhibition of the
activity of EGLNs.
Thioredoxin/thioredoxin reductase system also plays a critical
role in the generation of deoxyribonucleotides, needed for DNA
synthesis, and is essential for cell proliferation [36]. A down-
regulation of TR1 under hypoxic conditions could be a possible
mechanism to induce cell cycle arrest. In fact, it has been
described previously that hypoxic conditions induce cell cycle
arrest [37], although there are studies showing that this cell cycle
arrest could be HIF-dependent [38].
On the other hand, the reduction in TR1 activity induced by
hypoxia, and the subsequent increase on intracellular H2O2, could
act as a positive feedback for some of the signaling pathways
activated under hypoxic conditions. In agreement with this
hypothesis, H2O2 has been shown to play an important role in
angiogenesis. Thus, H2O2 stimulates angiogenic responses in
cultured endothelial cells and smooth muscle cells and induces the
production of VEGF protein in different cell types [39].
Furthermore, an important role of peroxide signaling is the
potentiation of receptor tyrosine kinase signaling, including VEGF
receptor 2, by oxidation of protein tyrosine phosphatases (PTP)
that negatively regulate their signaling [40].
Finally, the thioredoxin/thioredoxin reductase 1 system has an
important role in transcriptional regulation. Some cysteine
residues of several transcriptions factors, such as NF-kB,
glucocorticoid receptor, AP1 or p53 [36], are reduced by
thioredoxin, and the DNA binding, of these factors, usually
require these cysteine residues to be in a reduced state. Therefore,
the decrease in TR1 activity under hypoxic conditions that we
have observed could be a mechanism to regulate the transcrip-
tional activity of these transcription factors. In the case of p53, a
reduction in its transcriptional activity could be critical for tumor
cells to avoid apoptosis and progress under hypoxic conditions.
Supporting Information
Figure S1 Knockdown of TR1 in EMT6 and DT cells.
EMT6 and DT cells were infected with retroviruses encoding a
TR1 shRNA (siTR1) or a scramble sequence as a control. RNA
was collected from control and knockdown cells and TR1 mRNA
levels determined by quantitative PCR and normalized by the
content of b-actin. A value of 1 (solid line) was assigned to the
normalized TR1 level of control cells. The normalized levels of
TR1 in knockdown cells samples are represented as fold over
control samples. Data show the results obtained in three
independent experiments and their average values.
(TIF)
Figure S2 Over-expression of TR1 in EMT6 and DT
cells. EMT6 and DT cells were infected with empty retroviruses
(Ctrl) or with retroviruses encoding the TR1 gene (TR1). (A) TR1
mRNA levels were measured by quantitative RT-PCR and
normalized by the content of b-actin. Data show the average
fold-change over control of three independent experiments 6 SE.
(B) TR1 and b-actin protein levels were determined by western
blotting in EMT6 or DT TR1 over-expressing cells.
(TIF)
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